You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Labcorp declares quarterly dividend of USD0.72 per share
10 July 2026 -

Laboratory services provider Labcorp Holdings Inc (NYSE:LH) announced on Thursday that its board of directors has declared a cash dividend of USD0.72 per share of common stock.

This amount is unchanged from the previous quarterly dividend.

The dividend will be paid on 11 September 2026, to stockholders of record as of the close of business on 28 August 2026.

Login
Username:

Password:


Related Headlines

MedPal AI acquires eMARx to expand digital care home platform

Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones

Labcorp declares quarterly dividend of USD0.72 per share

Aptamer Group launches Optimer-based Ebola diagnostic programme

SK bioscience to lead Gates Foundation-funded ROTOR project

Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases

Lilly declares Q3 2026 dividend

Abbott declares quarterly dividend of USD0.63 per share

Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Lilly declares Q2 2026 dividend

Collegium to acquire AZSTARYS from Corium Therapeutics

CVS Health announces quarterly dividend of USD0.665 per share

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026